Immutep (IMMP) Change in Account Payables (2014 - 2024)
Immutep's (IMMP) quarterly Change in Account Payables came in at $354268.5 in Q2 2024, down 83.8% YoY from $2.2 million in Q3 2023, and down 83.8% on a QoQ basis from $2.2 million in Q2 2023.
Immutep (IMMP) Change in Account Payables (2014 - 2024) Analysis & Trends
Immutep (IMMP) has 6 years of Change in Account Payables data on file, last reported at $354268.5 in Q2 2024.
- Quarterly Change in Account Payables fell 83.8% year-over-year to $354268.5 in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $34002.4 (up 102.73% YoY) and the FY2024 annual result came in at $354268.5, down 83.8% from the prior year.
- Change in Account Payables declined to $354268.5 in Q2 2024, from $2.2 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $2.2 million in Q2 2023 to a low of -$1.4 million in Q2 2020.
- A 3-year average of $382664.8 and a median of $354268.5 in 2024 frame the typical range for Change in Account Payables.
- The widest YoY moves for Change in Account Payables: up 83.8% in 2024, down 83.8% in 2024.
- Tracing IMMP's Change in Account Payables over 3 years: stood at -$1.4 million in 2020, then jumped by 256.96% to $2.2 million in 2023, then plunged by 83.8% to $354268.5 in 2024.
- The last three Change in Account Payables figures came in at $354268.5 (Q2 2024), $2.2 million (Q2 2023), and -$1.4 million (Q2 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -8.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 37.53 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Immutep | 56.46 Mn | -8.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 354,268.50 |
| Jun 30, 2024 | 354,268.50 |
| Jun 30, 2023 | 2.19 Mn |
| Jun 30, 2023 | 2.19 Mn |
| Jun 30, 2020 | -1.39 Mn |
| Jun 30, 2020 | -1.39 Mn |
| Jun 30, 2016 | -1.11 Mn |
| Jun 30, 2016 | -1.11 Mn |
| Jun 30, 2015 | -923,547.17 |
| Jun 30, 2015 | -923,547.17 |
| Jun 30, 2014 | -761,175.36 |
| Jun 30, 2014 | -761,175.36 |